Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway. (Q34132787)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

based on heuristic

inferred from title

tumor angiogenesis

1 reference

based on heuristic

inferred from title

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Yanmin Dong

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Binbin Lu

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Xiaoli Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Jing Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Li Lai

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Dali Li

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Yuanyuan Wu

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Yajuan Song

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Jian Luo

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Xiufeng Pang

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Zhengfang Yi

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

0 references

publication date

23 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

2097-2104

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20732905%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Endogenous angiogenesis inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

A novel peptide from human apolipoprotein(a) inhibits angiogenesis and tumor growth by targeting c-Src phosphorylation in VEGF-induced human umbilical endothelial cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in mice

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Preclinical pharmacokinetics and in vitro metabolism of brivanib (BMS-540215), a potent VEGFR2 inhibitor and its alanine ester prodrug brivanib alaninate.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Sorafenib for the treatment of advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Sunitinib: a newly approved small-molecule inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathway

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

STAT proteins: From normal control of cellular events to tumorigenesis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

STAT3: a critical transcription activator in angiogenesis.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

VEGF differentially activates STAT3 in microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Activated STAT3 is a mediator and biomarker of VEGF endothelial activation

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Cucurbitacins as kairomones for diabroticite beetles

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Cucurbitane-type compounds from Hemsleya carnosiflora antagonize ecdysteroid action in the Drosophila melanogaster BII cell line

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Cucurbitacins and cucurbitane glycosides: structures and biological activities

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Inhibitory effects of cucurbitane triterpenoids on Epstein-Barr virus activation and two-stage carcinogenesis of skin tumor. II.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Anticarcinogenic activity of natural sweeteners, cucurbitane glycosides, from Momordica grosvenori

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Cucurbitacin E-induced disruption of the actin and vimentin cytoskeleton in prostate carcinoma cells.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Cucurbitacin E targets proliferating endothelia

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Inhibitory effect of cucurbitacin E on pancreatic cancer cells growth via STAT3 signaling

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Inhibitory effect of cucurbitacin E on the proliferation of ovarian cancer cells and its mechanism

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Cucurbitacin E as a new inhibitor of cofilin phosphorylation in human leukemia U937 cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Screening of biochemical modulator by tumor cell permeability of doxorubicin

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Protocol for the fast chromatin immunoprecipitation (ChIP) method

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Vasculogenesis and angiogenesis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Disrupting tumour blood vessels

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Proliferation, apoptosis, and intratumoral vascularity in multiple myeloma: correlation with the clinical stage and cytological grade

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ167

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34132787&oldid=2082542466"